Drugs / hMSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06781333 | Apr 2025 → Dec 2027 expected | Alzheimer disease | Bernard (Barry) Baumel | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hMSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06781333 ↗ |
| Modality | Cell therapy | “Human Mesenchymal Stem Cells (hMSC)” NCT06781333 ↗ |
| Route | Intravenous | “one intravenous infusion” NCT06781333 ↗ |